Literature DB >> 17027185

[HIV controllers: a homogeneous group of HIV-1 infected patients with a spontaneous control of viral replication].

O Lambotte1, J-F Delfraissy.   

Abstract

We identified a group of chronically HIV-1-infected patients in whom viral replication is spontaneously controlled without antiretroviral treatment. These patients account for less than 1% of HIV-infected patients. They are defined according to a virological definition: plasma viral load less than 400 copies RNA/ml in more than 90% of the samples tested and HIV positive serology known for more than 10 years. They should never have received antiretroviral therapy. The CD4 T cell count is not taken into account, which differenciate these patients from long-term non progressors. Fifteen patients HIV controllers have been studied in a preliminary work with two main results: i) the demonstration of a strong HIV-specific CD8 immune response and ii) the amount of viral DNA in PBMCs is very low and stable along the time. The aim of the ANRS EP36 study group is to precize the immunological and virological characteristics of these patients. First data seem to confirm an essential role of CD8 T cells to control viral replication, the absence of defective virus, and a normal susceptibility of the CD4 T cells from these patients to the infection with various HIV strains. This group of patients is homogeneous and its study supports physiopathological studies. To go further, a national survey of these patients has been set up to allow future study.

Entities:  

Mesh:

Year:  2006        PMID: 17027185     DOI: 10.1016/j.patbio.2006.07.035

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  5 in total

1.  Approach to the management of paediatric HIV spontaneous controllers.

Authors:  Peter Zuidewind; Mark Cotton; Shaun Barnabas; Anita Janse Van Rensburg; Gert van Zyl; Carli Gordijn
Journal:  S Afr J Infect Dis       Date:  2022-06-30

2.  Reconstitution of intestinal CD4 and Th17 T cells in antiretroviral therapy suppressed HIV-infected subjects: implication for residual immune activation from the results of a clinical trial.

Authors:  Gabriella d'Ettorre; Silvia Baroncelli; Luca Micci; Giancarlo Ceccarelli; Mauro Andreotti; Prachi Sharma; Gianfranco Fanello; Fausto Fiocca; Eugenio Nelson Cavallari; Noemi Giustini; Alessandra Mallano; Clementina M Galluzzo; Stefano Vella; Claudio M Mastroianni; Guido Silvestri; Mirko Paiardini; Vincenzo Vullo
Journal:  PLoS One       Date:  2014-10-23       Impact factor: 3.240

3.  Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection.

Authors:  Matt A Price; Wasima Rida; William Kilembe; Etienne Karita; Mubiana Inambao; Eugene Ruzagira; Anatoli Kamali; Eduard J Sanders; Omu Anzala; Eric Hunter; Susan Allen; Vinodh A Edward; Kristin M Wall; Jianming Tang; Patricia E Fast; Pontiano Kaleebu; Shabir Lakhi; Gaudensia Mutua; Linda Gail Bekker; Ggayi Abu-Baker; Amanda Tichacek; Paramesh Chetty; Mary H Latka; Pholo Maenetje; Heeran Makkan; Freddie Kibengo; Fran Priddy; Jill Gilmour
Journal:  J Infect Dis       Date:  2019-07-02       Impact factor: 5.226

4.  Elevated Expression of miR-19b Enhances CD8+ T Cell Function by Targeting PTEN in HIV Infected Long Term Non-progressors With Sustained Viral Suppression.

Authors:  Lin-Bo Yin; Cheng-Bo Song; Jie-Fu Zheng; Ya-Jing Fu; Shi Qian; Yong-Jun Jiang; Jun-Jie Xu; Hai-Bo Ding; Hong Shang; Zi-Ning Zhang
Journal:  Front Immunol       Date:  2019-01-11       Impact factor: 7.561

Review 5.  Blood Levels of Galectin-9, an Immuno-Regulating Molecule, Reflect the Severity for the Acute and Chronic Infectious Diseases.

Authors:  Hiroko Iwasaki-Hozumi; Haorile Chagan-Yasutan; Yugo Ashino; Toshio Hattori
Journal:  Biomolecules       Date:  2021-03-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.